Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18344965 | 1.00 | CA12 (0.36) | CA12CA1CA2CA9TSHR | |
| SCHEMBL18344966 | 1.00 | CA12 (0.36) | CA12CA1CA2CA9TSHR | |
| SCHEMBL1150995 | 0.81 | DPP4 (0.40) | CA12CA1CA2CA9 | |
| SCHEMBL18344821 | 0.76 | SMN1; SMN2 (0.47) | — | |
| SCHEMBL6237112 | 0.76 | SMN1; SMN2 (0.47) | — | |
| SCHEMBL944888 | 0.75 | PDK1 (0.39) | CA12CA1CA2CA9TSHR | |
| SCHEMBL6231704 | 0.74 | — | — | |
| SCHEMBL925416 | 0.72 | CA12 (0.40) | CA12CA1CA2CA9TSHR | |
| SCHEMBL6237107 | 0.71 | L3MBTL3 (0.35) | TSHR | |
| SCHEMBL22231455 | 0.71 | HSD11B1 (0.44) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023091707-A1 | BICYCLIC INHIBITORS OF JAK AND METHODS OF USE | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2023-05-25 | — | — | WO | disclosed |